Neuromyelitis Optica Spectrum Disorder Resembling Wernicke's Encephalopathy: A Case Report and Review of the Literature.
Sloan LynchNil Saez CalverasAnik AminPublished in: The Neurohospitalist (2024)
We describe a case of Neuromyelitis Optica Spectrum Disorder (NMOSD) mimicking Wernicke's Encephalopathy (WE) to highlight an atypical presentation of NMOSD. A 39-year-old female presented with subacute encephalopathy and progressive ophthalmoplegia. Her MRI revealed T2 hyperintensities involving the mammillary bodies, periaqueductal grey matter, medial thalami, third ventricle, and area postrema. Whole blood thiamine levels were elevated and she did not improve with IV thiamine. CSF was notable for lymphocytic pleocytosis and elevated protein. She tested positive for serum Aquaporin-4 (AQP4) antibody. Subsequent imaging revealed multilevel lesions in the cervical and thoracic spinal cord. Her CSF GFAP antibody also came back positive. She steadily and significantly improved after high-dose IV steroids and plasmapheresis. She later started on chronic rituximab therapy. This represents a unique case of NMOSD presenting with the classical clinical and imaging features of WE, as opposed to the typical presenting symptoms of NMOSD. As such, demyelinating disorders should be considered when there is concern for diencephalic and midline pathologies, particularly without classic WE risk factors. Conversely, clinicians should be aware of secondary nutritional complications arising from severe area postrema syndrome.
Keyphrases
- spectrum disorder
- early onset
- spinal cord
- risk factors
- high dose
- case report
- high resolution
- single cell
- multiple sclerosis
- spinal cord injury
- low dose
- magnetic resonance imaging
- neuropathic pain
- diffuse large b cell lymphoma
- white matter
- palliative care
- mitral valve
- pulmonary hypertension
- heart failure
- physical activity
- contrast enhanced
- small molecule
- drug induced
- left ventricular
- cell therapy
- coronary artery
- chronic lymphocytic leukemia
- replacement therapy